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ABSTRACT: We describe a series of easily accessible, visible-light-sensitive (λ > 500 nm) BODIPY (boron-dipyrromethene)-
based photoprotecting groups (PPGs) for primary and secondary amines, based on a carbamate linker. The caged compounds
are stable under aqueous conditions for 24 h and can be eﬃciently uncaged in vitro with visible light (λ = 530 nm). These
properties allow eﬃcient photodeprotection of amines, rendering these novel PPGs potentially suitable for various applications,
including the delivery of caged drugs and their remote activation.
■ INTRODUCTION
The bright prospects for the application of light in chemistry
and biology stimulates increasing attention for photochemical
control of function in recent years.1 Light can be used as a
regulatory element for biological systems because of its low
toxicity (in the so-called therapeutic window λ = 650−900
nm2), orthogonality with most bioactive compounds, high
spatiotemporal precision of delivery, control over quality and
quantity, tissue penetration, and lack of contamination of
samples.3
At the molecular level, photocontrol over bioprocesses can
be achieved by the incorporation of photosensitive moieties in
the structure of bioactive compounds. Two fundamental
approaches are being explored. In the ﬁrst one,4 molecular
photoswitches are used to reversibly turn on and oﬀ the activity
of the drug.5 In the second one, photoprotecting groups
(PPGs) are being used to suppress the activity of the drug until
it is activated with light.1a,6 In this approach, frequently, more
pronounced changes in activity prior to and after irradiation are
obtained.7 Commonly applied PPGs include coumarin,8 ortho-
nitrobenzyl,9 salicylic alcohol,10 and nitroindolinyl derivatives;11
the synthesis and mechanism of action of these groups are well-
described.12
Functional groups protected by PPGs are usually carboxylic
acids,13 alcohols,14 and amines.15 These groups are abundant in
drugs and biomolecules and are usually playing an important
role in their activity.16 Amines, in particular, function as
neurotransmitters, antibiotics, and anticancer drugs. Photo-
protection of dopamine,17 histidine,17 GABA18,19 and Vemur-
afenib20 has been reported. Photoprotecting groups can also be
used for controlling complex biological processes, like protein
dimerization21 or gene activation22 and gene silencing.23
Despite many successful applications, new PPGs are needed
that address drawbacks of existing agents, including slow
deprotection reactions and deprotections that require UV
light,24 which is toxic to tissues and is often scattered before
reaching the drug in the body. Because of the many potential
applications, we were interested in addressing these challenges
by designing a PPG with beneﬁcial properties for the use in
biological systems.
In general, when designing PPGs for biological applications,
one has to ensure a few of their key properties:6a,25 eﬃciency of
uncaging, narrow absorption maximum and low absorbance
outside of this range, high molar absorptivity at irradiation
wavelength, chemical stability and solubility in aqueous media,
and lack of toxicity of the PPGs as well as the products of
deprotection. Another important factor is the wavelength of
light needed for the deprotection, which should be as long as
possible (up to red and near-IR) for better light penetration of
tissues and a lower toxicity.
Recently, the group of Klan and Wirz presented data
suggesting that BODIPY (boron-dipyrromethene) has a similar
frontier orbital structure to that of coumarines or xanthenes,26
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rendering it a possible PPG. BODIPY derivatives are widely
used as probes,27 laser dyes,28 photosensitizers,29 sensors,30
dyads,31 catalysts,32 emission contrasts,33 and cell visualization
agents.34,35 This wide variety of applications is enabled by the
advantageous properties, such as stability in various media,
sharp absorbance peaks, low toxicity, high quantum yields, and
vivid color shifts obtained when changing various stimuli.
In the literature, there are three cases where meso-BODIPY
derivatives were used as PPGs. Winter and co-workers36
studied the deprotection of carboxylic acids from BODIPY with
diﬀerent substituents (Figure 1a). The modiﬁcations of the
electronic properties of the BODIPY moiety resulted in
diﬀerent λmax and eﬃciency of deprotection in DCM. The
authors observed that the BODIPY derivative with chlorine as
substituents on the ring (X = Cl) was the fastest to react,
releasing acetic acid within an hour, which is, however, not
eﬃcient enough for the compound to be used in most
biological applications.
A faster and more eﬃcient BODIPY-based PPG has been
proposed by the group of Weinstain.17 The compound, in
Figure 1. Comparison of reported BODIPY photoprotecting groups and those described in this work.
Scheme 1. Synthesis of Activated Carbonates 4−6 and Protection of 4-Fluorobenzylamine and 4-Fluoro-N-methylbenzylamine
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which the amine is connected to the BODIPY protecting group
through a carbamate linker (Figure 1b), could be uncaged fast
and was proved to be stable in aqueous media. The λmax of
these compounds was slightly red-shifted compared to a
nonsubstituted BODIPY core (540 nm). The authors also used
their PPG to release dopamine and histidine. The uncaged
amines were active, as was shown on rat cortical/hippocampal
neurons for dopamine and HeLa cells for histidine. The
experiments proved that the approach was compatible with
biological systems by showing the diﬀerence in activity of
protected and deprotected amines in vitro. Although the PPG
was eﬃcient and worked fast, it was synthesized from a
premade, diﬃcult to prepare, and expensive BODIPY dye.
During the preparation of this article, the groups of Winter and
Weinstain reported the use of dimethyl-boron based BODIPYs
for the fast release of methanol, chlorine, and a variety of
(thio)acids.37 A diﬀerent approach was proposed by the group
of Urano,38 who used a BODIPY protecting group for phenols
by attaching the phenol oxygen to the boron atom of the
BODIPY core. Deprotection with blue-green light of λmax = 500
nm proceeded relatively fast (20−30 min). In this system, the
protection of amines was also shown, but it required the use of
an additional phenolic linker. The two initial reports inspired
our design: To enhance the practicality of PPGs, we have
chosen the BODIPY core because of its stability in various
media and long wavelength of light needed for the deprotection
compared to the other commonly used PPGs. To ensure no
overlap with the commonly used bioactive compounds and the
penetration of the tissue, our aim was to shift the deprotection
wavelength even further while achieving a fast deprotection. To
achieve this, we decided to modify the BODIPY core with
halogen atoms, instead of alkyl groups, with the ease of
synthesis in mind. However, as opposed to the literature
approach that uses halogenated BODIPYs,39 we also installed
the carbamate functionality to facilitate the deprotection
reaction. Furthermore, 4-ﬂuorobenzylamine and 4-ﬂuoro-N-
methylbenzylamine were chosen as model amines for
protection because of the ease of observing the photo-
deprotection in 19F NMR (Figure 1c).
■ RESULTS AND DISCUSSION
Model protected amines 7−14 were prepared using the
synthetic route shown below (Scheme 1).
The synthesis started with the preparation of BODIPY ester
1 in 47% yield, using an adapted procedure, based on
experimental results described in the literature.39,40 Subsequent
hydrolysis of the ester and reaction with 4-nitrophenyl
chloroformate yielded carbonate 3 in 59% overall yield. In
our hands, this reaction proved to be scalable up to 0.5 g. In the
next step, we attempted halogenation of carbonate 3.
Chlorination was performed using NCS (2 portions of 5
equiv), modifying the procedure from Cosa et al.37 With a
reaction time of up to 3 d, the compound was obtained in a
very good yield of 90%. Analogous bromination using NBS
proceeded faster (30 min) and did not require a second
addition of the reagent, providing 93% of compound 5. This
approach was, however, much less successful for iodination.
Considerable amounts of monohalogenated product were being
formed, even when 10 equiv of fresh NIS was being used. (For
details, see the Supporting Information.) In this case, we chose
to use ICl as the iodinating agent. The addition of an ICl
solution to a suspension of ZnO and compound 3 in THF at 0
°C gave the disubstituted carbonate in 87% yield. With the
activated carbonates 3−6 in hand, the protection of model
primary and secondary amines 4-ﬂuorobenzylamine and 4-
ﬂuoro-N-methylbenzylamine was performed, by simply stirring
the solution of the amine, carbonate, and pyridine in THF at rt.
Unsubstituted carbamates 7 and 11 (X = H) were obtained
in 92 and 90% yields, respectively. Halogenated carbamates 8−
10 were obtained in moderate yields (61−65%), starting with
Cl, Br, and I substituted carbonates. We hypothesize that the
drop in yield comparing the formation of halogenated and
unsubstituted carbamates (7 and 11 vs 8−10 and 12−14) is a
result of a change of electron density in the BODIPY
conjugated system, where the benzylic position becomes
more electrophilic. An attack of the amine is also feasible at
this position, with concurrent liberation of CO2 from the
carbonate, leading to the formation of amines instead of
carbamates (Scheme 1). (For the NMR of one of the side
products, 15, see section 6 in the Supporting Information.) The
ratio of the formation of amines to carbamates was
approximately 1:2 for carbamates prepared from primary
amines and about 1:1 for carbamates prepared from secondary
amines as estimated from the crude NMR spectra. (See the
sections 5 and 6 in the Supporting Information.) The eﬀect was
found to be more pronounced for 4-ﬂuoro-N-methylbenzyl-
amine.
To solve this problem, our synthesis route was modiﬁed by
halogenating carbamates 7 and 11 instead of carbonate 3
(Scheme 2). The reactions were performed in a similar manner
to the ones described before for the halogenation of carbonate.
The desired compounds were obtained in 73−80% yields for
the derivatives of compound 7 and 69−73% for the derivatives
of compound 11, respectively. This synthetic route provides
higher overall yields and is a valuable alternative provided that
the late-stage halogenation reaction does not aﬀect the moiety
being protected.
With the protected amines in hand, the eﬃciency of the
uncaging was studied following the process with UV−vis
spectroscopy, 19F NMR, and UPLC, which was also used to
measure the stability of the compounds in aqueous media. For
UV−vis measurements, compounds 7−14 in DMSO/phos-
phate buﬀer pH = 7.5 were irradiated with an LED light source
(λ = 530 nm, 810 mW, 0.2 cm distance) for 10 min and UV−
vis spectra were recorded every 30 s.
A rapid decrease of the absorbance of the bands attributed to
the BODIPY core was observed, in accordance with the
anticipated uncaging (Figure 2). Using the monoexponential
ﬁtting (Supporting Information), we calculated the half-lives of
the caged molecules under irradiation (Table 1).
Scheme 2. Late-Stage Halogenation of Carbamates
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According to the obtained data, all carbamates react fast
(similar half-lives, less than 5 min) under irradiation. For
compounds 9 and 13, we measured the quantum yields for the
deprotection reaction under irradiation with green light. The
obtained values were 4.2 × 10−5 for compound 9 and 3.8 ×
10−5 for compound 13. (See the details in the Supporting
Information.) Substitution of the pyrrole ring with halogens
slightly shifts the main UV−vis peak maximum attributed to the
BODIPY core and gives rise to another red-shifted band. The
eﬀect is more pronounced for carbamates obtained from
secondary amines.
To check if the deprotection reaction proceeds in a clean
fashion, we followed the process by 19F NMR. (See the
Supporting Information for details.) The spectra proved that
one ﬂuorinated compound is being released. To establish that
this compound is indeed the uncaged amine, we used UPLC
measurements. Samples of compounds 7−14 were prepared in
DMSO/phosphate buﬀer (details in the Supporting Informa-
tion), and UPLC traces of the fresh samples and after 1 h of
irradiation with λ = 530 nm light were measured. In parallel, we
prepared a second set of samples for every carbamate. These
samples were used to check the stability of compounds 7−14 in
aqueous media, and instead of being irradiated, they were
stored at room temperature in the dark. UPLC traces of these
samples were measured alongside the irradiated set: once for
fresh samples, then after 3 and 24 h. To estimate the relative
amount of carbamates in the samples, the absorbance of their
BODIPY signals at λ = 520 nm was measured (Figure 3). (For
the UPLC traces, see the Supporting Information.)
Most of the studied compounds could be uncaged upon
green-light irradiation (λ = 530 nm) for 1 h. The UPLC
retention times of the products formed in these samples were
consistent with those measured for appropriate amine standards
(Supporting Information). In general, 4-ﬂuoro-N-methylbenzyl-
amine was released more eﬃciently (compounds 11−14) than
4-ﬂuorobenzylamine (compounds 7−10). For compounds 7
and 14, partial precipitation from the solution was observed,
proving its inferior water solubility properties compared to the
other carbamates. Other protected amines proved to be soluble
and stable (<10% degradation) under aqueous conditions even
after 24 h of incubation at room temperature.
■ CONCLUSION
Green-light-sensitive (λ = 530 nm) BODIPY photoprotecting
groups were designed and used to protect primary and
secondary amines. The deprotection reaction occurred fast in
aqueous media and yielded the amines in unmodiﬁed forms.
Protected compounds based on a halogenated BODIPY core
proved to be more soluble in aqueous media. Brominated
carbamates 9 and 13 had the best characteristics for PPGs
under the conditions studied: the deprotection was fast; λmax
shifted to 560 nm, and the compounds were stable in aqueous
solutions. Finally, iodinated carbamates 10 and 14 showed
nearly no ﬂuorescence and fast cleavage, but their solubility in
aqueous media was limited. Carbonates obtained in the
synthesis can be readily reacted with a variety of amines,
making them highly versatile building blocks. Short times for
deprotection, wavelength used, and stability of the obtained
compounds make the PPGs an attractive alternative to
commonly used ortho-nitrobenzyl compounds and coumarines.
Although the new protecting groups can be used for in vitro
and cell studies by avoiding the use of toxic UV light, their use
in vivo is still limited due to poor body penetration of green
light. The next step for the development of BODIPY
photoprotecting groups would be shifting their λmax to the
therapeutic window region (650−900 nm) and enhance their
solubility in aqueous media. The novel PPGs presented here for
Figure 2. UV−Vis spectra of compounds 10 and 14 (20 μM in 20%
DMSO/5 mM phosphate buﬀer pH = 7.5) under irradiation with λ =
530 nm LED light. Spectra were measured every 30 s.
Table 1. Photochemical Properties and Half-Lives of Compounds 7−14 upon Irradiation with λ = 530 nm
compound no. X R half-life [min] λmax1 λmax2 ελmax1/10
3 [cm−1 mol−1] ελmax2/10
3 [cm−1 mol−1] ε530nm/10
3 [cm−1 mol−1]
7 H H 0.73 518 42 16
8 CI H 0.94 516 544 9.4 9.2 9.1
9 Br H 1.62 505 550 19 11 16
10 I H 1.99 511 558 14 0.6 12
11 H CH3 2.12 518 46 29
12 CI CH3 2.06 519 550 22 21 21
13 Br CH3 0.96 521 553 30 28 29
14 I CH3 1.87 531 565 27 25 27
Figure 3. Stability and photocleavage of BODIPY carbamates.
Comparison of normalized absorbance signals for compounds 7−14,
0.125 mM in 25% DMSO/5 mM phosphate buﬀer, pH = 7.5, at λ =
520 nm. (For non-normalized values, see the Supporting Information.)
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the facile photodeprotection of amines with visible light makes
these systems also highly attractive for various other future
applications.
■ EXPERIMENTAL PROCEDURES
General Information. Starting materials, reagents, and solvents
were purchased from Sigma−Aldrich, Acros, and Combi-Blocks and
were used without any additional puriﬁcation. Solvents for the
reactions were puriﬁed by passage through solvent puriﬁcation
columns (MBraun SPS-800). 4-Nitrophenol chloroformate was
obtained from Combi-Blocks. Unless stated otherwise, all reactions
were carried using standard Schlenk techniques and were ran under a
nitrogen atmosphere in the dark. The reaction progress was monitored
by TLC. Thin-layer chromatography analyses were performed on
commercial Kieselgel 60, F254 silica gel plates with the ﬂuorescence
indicator UV254 (Merck, TLC silica gel 60 F254). For the detection
of components, UV light at λ = 254 nm or λ = 365 nm was used.
Column chromatography was performed on commercial Kieselgel 60,
0.04−0.063 mm, Macherey-Nagel.
UPLC traces were measured on a Thermo Fisher Scientiﬁc LC/MS:
UPLC model Vanquish, MS model LTQ with an iontrap and HESI
(heated ESI) ionization source with positive and negative modes. UV−
Vis absorption spectra were recorded on an Agilent 8453 UV−vis
absorption spectrophotometer. Irradiation at 532 nm was performed
using Sahlmann Photochemical Solutions LEDs, type LXMLPM01,
opt. power 810 mV. The obtained UV−vis spectra were baseline
corrected. Nuclear magnetic resonance spectra were measured with an
Agilent Technologies 400-MR (400/54 Premium Shielded) spec-
trometer (400 MHz). All spectra were measured at room temperature
(25 °C). Chemical shifts for the speciﬁc NMR spectra were reported
relative to the residual solvent peak in ppm: CDCl3, δH = 7.26; CDCl3,
δC = 77.16; DMSO-d6, δH = 2.50; DMSO-d6, δC = 39.52. The
multiplicities of the signals are denoted by s (singlet), d (doublet), t
(triplet), q (quartet), and m (multiplet). All 13C NMR spectra are 1H-
broad band decoupled. High-resolution mass spectrometric measure-
ments were performed using a Thermo scientiﬁc LTQ OrbitrapXL
(ion trap) spectrometer with ESI ionization. The molecule ions M+,
[M + H]+, and [M − X]+ are given in m/z. Melting points were
recorded using a Stuart analogue capillary melting point SMP11
apparatus.
(5,5-Diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-dipyrrolo[1,2-c:2′,1′-
f ][1,3,2]diazabo-rinin-10-yl)methyl Acetate (1) (According to
Combined Literature Procedures38,40). 2-Chloro-2-oxoethyl acetate
(0.60 mL, 5.6 mmol, 1.2 equiv) was added to a solution of 2,4-
dimethylpyrrole (1.0 mL, 9.3 mmol, 2.0 equiv) in dry DCM (40 mL)
under a nitrogen atmosphere. The reaction mixture was stirred in the
dark at room temperature for 24 h. After this time, the ﬂask was
opened and TEA (3.2 mL, 28 mmol, 6.0 equiv) was added. The
resulting mixture was allowed to stir for 15 min. Then, the ﬂask was
again put under a nitrogen atmosphere, and boron triﬂuoride diethyl
etherate (5.2 mL, 42 mmol, 9.0 equiv) was added. After 1 h, another
portion of TEA (3.2 mL, 28 mmol, 6.0 equiv) and boron triﬂuoride
diethyl etherate (5.2 mL, 42 mmol, 9.0 equiv) was added. Then, silica
was added to the ﬂask, and the solvents were evaporated. Compound 1
was puriﬁed by column chromatography using pentane/Et2O (2:1; v/
v) as the eluent. The product was obtained as red-gold crystals (700
mg, 47% yield): Rf = 0.7 (DCM); mp = 184−187 °C; 1H NMR (400
MHz, chloroform-d) δ 2.13 (s, 3H, COCH3), 2.36 (s, 6H, 2 ×
ArCH3), 2.53 (s, 6H, 2 × ArCH3), 5.30 (s, 2H, ArCH2CO), 6.08 (s,
2H, 2 × ArH); 19F NMR (376 MHz, chloroform-d) δ −146.43 (dd, J
= 65.1, 32.5 Hz); HRMS (ESI+) calcd for [M + H]+
(C16H20BF2N2O2) 321.1580, found 321.1585.
1H spectrum is in
agreement with published data.38
(5,5-Diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-dipyrrolo[1,2-c:2′,1′-
f ][1,3,2]diazaborinin-10-yl)methanol (2) (According to a Literature
Procedure38,41). A mixture of aqueous NaOH solution (6.3 mL, 0.10
M, 0.40 equiv) and methanol (30 mL) was stirred for 10 min and then
added to a solution of compound 1 (0.50 g, 1.6 mmol) in DCM (15
mL). The reaction mixture was stirred for 4 h in the dark at room
temperature. After this time, the solvents were partially evaporated and
the residue was extracted with EtOAc (3 × 30 mL). The combined
organic layers were washed with 1 M HCl (2 × 20 mL) and brine (1 ×
20 mL) and dried with MgSO4. Compound 2 was puriﬁed by column
chromatography (pentane/Et2O, gradient 2:1 → 0:1; v/v). The
product was obtained as a red precipitate (350 mg, 81% yield): Rf =
0.3 (DCM); mp = 247−249 °C; 1H NMR (400 MHz, chloroform-d) δ
2.51 (s, 6H, 2 × ArCH3), 2.52 (s, 6H, 2 × ArCH3), 4.91 (s, 2H,
ArCH2CO), 6.08 (s, 2H, 2 × ArH);
19F NMR (376 MHz, chloroform-
d) δ −146.52 (dd, J = 65.3, 32.4 Hz); HRMS (ESI+) calcd for [M +
H]+ (C14H18BF2N2O) 279.1475, found 279.1488.
1H spectrum is in
agreement with published data.41
(5,5-Diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-dipyrrolo[1,2-c:2′,1′-
f ][1,3,2]diazaborinin-10-yl)methyl (4-Nitrophenyl)carbonate (3).
To a solution of 4-nitrophenyl chloroformate (870 mg, 4.3 mmol,
3.4 equiv) in dry DCM (50 mL) was added pyridine (0.35 mL, 4.3
mmol, 3.4 equiv) under a nitrogen atmosphere. The formed
suspension was then added dropwise to a solution of compound 2
(350 mg, 1.3 mmol) in dry DCM (100 mL) and DIPEA (0.63 mL, 4.3
mmol, 4.3 equiv) at 0 °C, in the dark. The reaction mixture was
allowed to warm up and was stirred for 4 h. After this time, the
solution was ﬁltered through silica using DCM. The solvents were
evaporated, and the product was puriﬁed by column chromatography
using pentane/Et2O/DCM as the eluent (2 stages with a gradient of
pentane/Et2O 5:1 → 2:1, then DCM 100%). Compound 3 was
obtained as a pink precipitate (440 mg, 79% yield): Rf = 0.8 (DCM);
mp = 203−205 °C; 1H NMR (400 MHz, chloroform-d) δ 2.46 (s, 6H,
2 × ArCH3), 2.55 (s, 6H, 2 × ArCH3), 5.57 (s, 2H, ArCH2OCO),
6.12 (s, 2H, 2 × BArH), 7.40 (d, 3J = 9.1 Hz, 2H, 2 × OCCH), 8.29
(d, 3J = 9.2 Hz, 2H, 2 × NO2CH);
19F NMR (376 MHz, chloroform-
d) δ −146.16 (dd, J = 64.9, 32.3 Hz); 13C NMR (101 MHz,
chloroform-d) δ 14.8, 15.8, 61.7, 121.6, 122.7, 125.4, 130.9, 132.6,
141.4, 145.6, 152.2, 155.2, 157.3; HRMS (ESI+) calcd for [M + H]+
(C21H21BF2N3O5) 444.1537, found 444.1533.
(5,5-Diﬂuoro-2,8-dichloro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-
dipyrrolo[1,2-c:2′,1′-f ][1,3,2]diazaborinin-10-yl)methyl (4-
Nitrophenyl)carbonate (4). To a solution of compound 3 (50 mg,
0.11 mmol) in dry THF (0.5 mL) was added a solution of NCS (75
mg, 0.56 mmol, 5.0 equiv) in dry THF (0.5 mL) under a nitrogen
atmosphere. The reaction was stirred until full consumption of the
starting material was observed (TLC). After this time (up to 3 days),
the solvent was evaporated and the crude mixture was puriﬁed by ﬂash
chromatography using DCM as the eluent. The product was obtained
as a dark purple precipitate (52 mg, 90% yield): Rf = 0.9 (DCM); mp
= 208−211 °C; 1H NMR (400 MHz, chloroform-d) δ 2.49 (s, 6H, 2 ×
ArCH3), 2.61 (s, 6H, 2 × ArCH3), 5.59 (s, 2H, ArCH2OCO), 7.40 (d,
J = 9.2 Hz, 2H, 2 × OCCH), 8.30 (d, J = 9.2 Hz, 2H, 2 × NO2CH);
19F NMR (376 MHz, chloroform-d) δ −145.91 (dd, J = 62.9, 31.4
Hz); 13C NMR (101 MHz, chloroform-d) δ 12.7, 13.2, 61.43, 121.6,
124.1, 125.4, 130.9, 131.7, 136.1, 145.7, 152.1, 154.4, 155.1; HRMS




Nitrophenyl)carbonate (5). To a solution of compound 3 (50 mg,
0.11 mmol) in dry THF (0.5 mL) was added a solution of NBS (100
mg, 0.56 mmol, 5 equiv) in dry THF (0.5 mL) under a nitrogen
atmosphere. The reaction was stirred for 30 min at room temperature.
After that time, the solvent was evaporated and the crude mixture was
puriﬁed by ﬂash chromatography using DCM as the eluent. The
product was obtained as a violet-green precipitate (63 mg, 93% yield):
Rf = 0.9 (DCM); mp = 214−217 °C; 1H NMR (400 MHz,
chloroform-d) δ 2.49 (s, 6H, 2 × ArCH3), 2.61 (s, 6H, 2 × ArCH3),
5.59 (s, 2H, ArCH2OCO), 7.40 (d, J = 9.0 Hz, 2H, 2 × OCCH), 8.30
(d, J = 9.0 Hz, 2H, 2 × NO2CH);
19F NMR (376 MHz, chloroform-d)
δ −146.27 (dd, J = 62.7, 31.4 Hz); 13C NMR (101 MHz, chloroform-
d) δ 14.0, 15.0, 61.6, 113.4, 121.6, 125.4, 131.3, 131.6, 138.7, 145.7,
152.1, 155.1, 155.8; HRMS (ESI+) calcd for [M + H]+
(C21H19BBr2F2N3O5) 601.9727, found 601.9729.
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Nitrophenyl)carbonate (6). To a suspension of compound 3 (44
mg, 99 μmol) and ZnO (29 mg, 0.36 mmol, 3.6 equiv) in dry THF (7
mL) was added a solution of ICl (50 mg, 0.31 mmol, 3.1 equiv) in dry
THF (2 mL) under a nitrogen atmosphere, at 0 °C. The reaction was
stirred for 15 min. After this time, the solvent was evaporated and the
crude mixture was puriﬁed by ﬂash chromatography using DCM as the
eluent. The product was obtained as a violet-gold precipitate (60 mg,
87% yield): Rf = 0.9 (DCM); mp = 194−197 °C; 1H NMR (400 MHz,
chloroform-d) δ 2.52 (s, 6H, 2 × ArCH3), 2.65 (s, 6H, 2 × ArCH3),
5.60 (s, 2H, ArCH2OCO), 7.40 (d, J = 9.1 Hz, 2H, 2 × OCCH), 8.30
(d, J = 9.1 Hz, 2H, 2 × NO2CH);
19F NMR (376 MHz, chloroform-d)
δ −145.59 (dd, J = 63.3, 31.6 Hz); 13C NMR (101 MHz, chloroform-
d) δ 16.4, 18.4, 61.9, 121.6, 125.4, 130.3, 131.7, 132.5, 143.4, 145.7,
152.0, 155.1, 158.6; HRMS (ESI+) calcd for [M + H]+
(C21H19BI2F2N3O5) 695.9469, found 695.9470.
(5,5-Diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-dipyrrolo[1,2-c:2′,1′-
f ][1,3,2]diazaborinin-10-yl)methyl (4-Fluorophenyl)carbamate (7).
To a solution of compound 3 (100 mg, 0.23 mmol) in dry THF (5
mL) was added a solution of pyridine in THF (1.0 M, 75 μL, 75 μmol,
0.24 equiv) under a nitrogen atmosphere. After the mixture was stirred
for 15 min at room temperature, a solution of 4-ﬂuorobenzylamine in
THF (1.0 M, 0.34 mL, 0.34 mmol, 0.9 equiv) was added. The reaction
was then stirred for an additional 3 h. After that time, DCM (20 mL)
and brine (20 mL) were added and the formed phases were separated.
After the organic layer was washed with 1 M HCl (3 × 20 mL), 0.1 M
NaOH (4 × 20 mL), and brine (2 × 20 mL), it was dried with MgSO4
and the solvent was evaporated. The crude mixture was then puriﬁed
by ﬂash chromatography using DCM as the eluent. The product was
obtained as an orange-gold precipitate (89 mg, 92% yield): Rf = 0.5
(DCM); mp = 182−184 °C; 1H NMR (400 MHz, chloroform-d) δ
2.39 (s, 6H, 2 × ArCH3), 2.52 (s, 6H, 2 × ArCH3), 4.35 (d, J = 5.9 Hz,
2H, CCH2NH), 5.11 (s, 1H, CONH), 5.33 (s, 2H, ArCH2OCO), 6.07
(s, 2H, 2 × ArH), 7.02 (t, J = 8.6 Hz, 2H, CH2CCH), 7.23 (t, J = 5.5
Hz, 2H, FCCH); 19F NMR (376 MHz, chloroform-d) δ −146.43 (m, J
= 65.1, 32.6 Hz), −114.72 (m); 13C NMR (101 MHz, chloroform-d) δ
14.6, 15.6, 44.5, 58.1, 115.5, 115.7, 129.1, 129.1, 132.6, 133.5, 133.8,
141.6, 155.7, 156.5, 161.0, 163.4; HRMS (ESI+) calcd for [M + H]+
(C22H24BF3N3O2) 430.1908, found 430.1906.
(2,8-Dichloro-5,5-diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-
dipyrrolo[1,2-c:2′,1′-f ][1,3,2]diazaborinin-10-yl)methyl (4-
Fluorobenzyl)carbamate (8). Method A. To a solution of compound
4 (10 mg, 20 μmol) in dry THF (0.5 mL) was added a solution of
pyridine in THF (1.0 M, 4.7 μL, 4.7 μmol, 0.24 equiv) under a
nitrogen atmosphere. After the mixture was stirred for 15 min at room
temperature, a solution of 4-ﬂuorobenzylamine in THF (1.0 M, 30 μL,
30 μmol, 1.5 equiv) was added. The reaction was then stirred for an
additional 3 h. After that time, DCM (10 mL) and brine (10 mL) were
added and the formed phases were separated. After the organic layer
was washed with 1 M HCl (3 × 10 mL), 0.1 M NaOH (4 × 10 mL),
and brine (2 × 10 mL), it was dried with MgSO4 and the solvent was
evaporated. The crude mixture was then puriﬁed by ﬂash
chromatography using DCM as the eluent. The product was obtained
as a purple precipitate (6.0 mg, 62%).
Method B. To a solution of compound 7 (10 mg, 23 μmol) in dry
THF (0.5 mL) was added a solution of NCS (16 mg, 116 μmol, 5
equiv) in dry THF (0.5 mL) under a nitrogen atmosphere. The
reaction was allowed to stir at rt overnight. After this time, another
portion of NCS was added (16 mg, 0.12 mmol, 5 equiv). After full
conversion of the starting material (TLC), the crude mixture was
puriﬁed by ﬂash chromatography using DCM as the eluent. The
product was obtained as a purple precipitate (8.5 mg, 73% yield).
Compound data: Rf = 0.6 (DCM); mp = 191−193 °C; 1H NMR
(400 MHz, chloroform-d) δ 2.40 (s, 6H, 2 × ArCH3), 2.56 (s, 6H, 2 ×
ArCH3), 4.36 (d, J = 5.9 Hz, 2H, CCH2NH), 5.10 (s, 1H, CONH),
5.34 (s, 2H, ArCH2OCO), 7.03 (t, J = 8.5 Hz, 2H, CH2CCH), 7.23
(d, J = 5.5 Hz, 2H, FCCH); 19F NMR (376 MHz, chloroform-d) δ
−146.42 (dd, J = 63.2, 31.6 Hz), −114.49 (td, J = 8.6, 4.4 Hz); 13C
NMR (101 MHz, chloroform-d) δ 12.6, 13.0, 44.6, 58.0, 115.6, 115.8,
129.1, 129.2, 130.9, 133.6, 134.3, 136.3, 153.6, 155.4, 161.1, 163.5;





Fluorobenzyl)carbamate (9). Method A. To a solution of compound
5 (50 mg, 83.2 μmol) in dry THF (10 mL) was added a solution of
pyridine in THF (0.50 M, 0.17 mL, 83.2 μmol, 1 equiv) under a
nitrogen atmosphere. After the mixture was stirred for 15 min at room
temperature, a solution of 4-ﬂuorobenzylamine in THF (0.50 M, 0.16
mL, 74.9 μmol, 0.9 equiv) was added. The reaction was then stirred for
an additional 3 h. After that time, DCM (10 mL) and brine (10 mL)
were added and the formed phases were separated. After the organic
layer was washed with 1 M HCl (3 × 10 mL), 0.1 M NaOH (4 × 10
mL), and brine (2 × 10 mL), it was dried with MgSO4 and the solvent
was evaporated. The crude mixture was then puriﬁed by ﬂash
chromatography using DCM as the eluent. The product was obtained
as a purple precipitate (16 mg, 36% yield).
Method B. To a solution of compound 7 (10 mg, 23 μmol) in dry
THF (0.5 mL) was added a solution of NBS (12 mg, 70 μmol, 3
equiv) in dry THF (0.5 mL) under a nitrogen atmosphere. The
reaction was then stirred at room temperature for 0.5 h. After this
time, the crude mixture was puriﬁed by ﬂash chromatography using
DCM as the eluent. The product was obtained as a purple precipitate
(11 mg, 80%).
Compound data: Rf = 0.6 (DCM); mp = 216−219 °C; 1H NMR
(400 MHz, chloroform-d) δ 2.42 (s, 6H, 2 × ArCH3), 2.58 (s, 6H, 2 ×
ArCH3), 4.36 (d, J = 5.8 Hz, 2H, CCH2NH), 5.10 (s, 1H, CONH),
5.35 (s, 2H, ArCH2OCO), 7.03 (t, J = 8.5 Hz, 2H, CH2CCH), 7.24
(d, J = 8.0 Hz, 2H, FCCH); 19F NMR (376 MHz, chloroform-d) δ
−146.12 (m, J = 63.0, 31.8 Hz), −114.50 (m); 13C NMR (101 MHz,
chloroform-d) δ 13.9, 14.8, 44.6, 58.2, 112.9, 115.6, 115.8, 129.2,
131.7, 133.5, 133.9, 138.9, 155.1, 155.4, 161.1, 163.5; HRMS (ESI+)
calcd for [M + NH4]




Fluorobenzyl)carbamate (10). Method A. To a solution of
compound 6 (50 mg, 71.9 μmol) in dry THF (10 mL) was added a
solution of pyridine in THF (0.50 M, 0.14 mL, 72 μmol, 1.0 equiv)
under a nitrogen atmosphere. After the mixture was stirred for 15 min
at room temperature, a solution of 4-ﬂuorobenzylamine in THF (0.50
M, 0.13 mL, 65 μmol, 0.90 equiv) was added. The reaction was then
stirred for an additional 3 h. After that time, DCM (10 mL) and brine
(10 mL) were added and the formed phases were separated. After the
organic layer was washed with 1 M HCl (3 × 10 mL), 0.1 M NaOH (4
× 10 mL), and brine (2 × 10 mL), it was dried with MgSO4 and the
solvent was evaporated. The crude mixture was then puriﬁed by ﬂash
chromatography using DCM as the eluent. The product was obtained
as a purple precipitate (30 mg, 61% yield).
Method B. To a suspension of compound 7 (10 mg, 23 μmol) and
ZnO (6.8 mg, 84 μmol, 3.6 equiv) in dry THF (0.5 mL) was added a
solution of ICl (11 mg, 70 μmol, 3.0 equiv) in dry THF (0.5 mL) at 0
°C in a nitrogen atmosphere. The reaction was allowed to stir for 10
min, after which the solvent was evaporated and the crude mixture
ﬁltrated through silica using DCM. The product was obtained as a
dark violet precipitate (12 mg, 76%).
Compound data: Rf = 0.6 (DCM); mp = 203−204 °C; 1H NMR
(400 MHz, chloroform-d) δ 2.44 (s, 6H, 2 × ArCH3), 2.62 (s, 6H, 2 ×
ArCH3), 4.36 (d, J = 5.5 Hz, 2H, CCH2NH), 5.12 (s, 1H, CONH),
5.35 (s, 2H, ArCH2OCO), 7.03 (t, J = 8.0 Hz, 2H, CH2CCH), 7.24 (t,
J = 6.0 Hz, 2H, FCCH); 19F NMR (376 MHz, chloroform-d) δ
−145.90 (m), −145.26 (m), −114.50; 13C NMR (101 MHz,
chloroform-d) δ 16.3, 18.2, 44.6, 58.5, 115.6, 115.8, 129.2, 129.5,
132.5, 133.0, 133.6, 143.5, 155.4, 157.9, 160.1, 161.1; HRMS (ESI+)
calcd for [M + NH4]
+ (C22H25BI2F3N4O2) 699.0112, found 699.0167.
(5,5-Diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-dipyrrolo[1,2-c:2′,1′-
f ][1,3,2]diazaborinin-10-yl)methyl (4-Fluorobenzyl)(methyl)-
carbamate (11). To a solution of compound 3 (100 mg, 230
μmol) in dry THF (5 mL) was added a solution of pyridine in THF
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(1.0 M, 0.054 mL, 54 μmol, 0.24 equiv) under a nitrogen atmosphere.
After the mixture was stirred for 15 min at room temperature, a
solution of 4-ﬂuoro-N-methylbenzylamine in THF (1.0 M, 0.34 mL,
340 μmol, 0.90 equiv) was added. The reaction was then stirred for an
additional 3 h. After that time, DCM (20 mL) and brine (20 mL) were
added and the formed phases were separated. After the organic layer
was washed with 1 M HCl (3 × 20 mL), 0.1 M NaOH (4 × 20 mL),
and brine (2 × 20 mL), it was dried with MgSO4 and the solvent was
evaporated. The crude mixture was then puriﬁed by ﬂash
chromatography using DCM as the eluent. The product was obtained
as an orange precipitate (90 mg, 90% yield): Rf = 0.5 (DCM); mp =
123−125 °C; 1H NMR (400 MHz, chloroform-d) δ 2.31 (s, 3H,
ArCH3), 2.40 (s, 3H, ArCH3), 2.53 (s, 6H, 2 × ArCH3), 2.78 (s, 1.5H,
0.5 × NCH3), 2.97 (s, 1.5H, 0.5 × NCH3), 4.34 (s, 1H, CCH2NCH3),
4.46 (s, 1H, CCH2NCH3), 5.32 (s, 1H, ArCH2OCO), 5.35 (s, 1H,
ArCH2OCO), 6.05 (s, 1H, ArH), 6.08 (s, 1H, ArH), 6.92 (t, J = 8.2
Hz, 1H, FCCH), 6.97−7.11 (m, 2H, CH2CCH), 7.18−7.24 (m, 1H,
FCCH); 19F NMR (376 MHz, chloroform-d) δ −146.34 (ddd, J =
65.2, 32.1, 9.2 Hz), −114.94 (dt, J = 47.0, 7.9 Hz); 13C NMR (101
MHz, chloroform-d) δ 14.7, 15.5, 33.7, 35.0, 51.9, 52.1, 115.3, 115.4,
115.5, 115.6, 122.2, 128.9, 129.5, 132.7, 132.7, 133.7, 133.9, 141.6,
155.5, 156.1, 156.5, 160.9, 161.0, 163.4, 163.5; HRMS (ESI+) calcd for
[M + H]+ (C23H26BF3N3O2) 444.2065, found 444.2062.
(2,8-Dichloro-5,5-diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-
dipyrrolo[1,2-c:2′,1′-f ][1,3,2]diazaborinin-10-yl)methyl (4-
Fluorobenzyl)(methyl)carbamate (12). Method A. To a solution of
compound 4 (10 mg, 20 μmol) in dry THF (0.5 mL) was added a
solution of pyridine in THF (1.0 M, 4.7 μL, 4.7 μmol, 0.24 equiv)
under a nitrogen atmosphere. After the mixture was stirred for 15 min
at room temperature, a solution of 4-ﬂuoro-N-methylbenzylamine in
THF (1.0 M, 30 μL, 30 μmol, 1.5 equiv) was added. The reaction was
then stirred for an additional 3 h. After that time, DCM (20 mL) and
brine (20 mL) were added and the formed phases were separated. The
organic layer was washed with 1 M HCl (3 × 20 mL), 0.1 M NaOH (4
× 20 mL), and brine (2 × 20 mL). Then it was dried with MgSO4, and
the solvent was evaporated. The crude mixture was then puriﬁed by
ﬂash chromatography using pentane/diethyl ether (3:1; v/v) as the
eluent. The product was obtained as a purple precipitate (3.5 mg, 35%
yield).
Method B. To a solution of compound 11 (10 mg, 23 μmol) in dry
THF (0.5 mL) was added a solution of NCS (15 mg, 0.11 mmol, 5
equiv) under a nitrogen atmosphere. The reaction was allowed to stir
at rt overnight. After this time, another portion of NCS was added (15
mg, 0.11 mmol, 5 equiv). Then the reaction was monitored with TLC
every hour. After completion, the crude mixture was puriﬁed by ﬂash
chromatography using DCM as the eluent. The product was obtained
as a purple precipitate (8 mg, 69% yield).
Compound data: Rf = 0.7 (DCM); mp = 157−159 °C; 1H NMR
(400 MHz, chloroform-d) δ 2.30 (s, 3H, ArCH3), 2.41 (s, 3H,
ArCH3), 2.57 (s, 6H, 2 × ArCH3), 2.78 (s, 1.5H, 0.5 × NCH3), 3.00
(s, 1.5H, 0.5 × NCH3), 4.34 (s, 1H, CCH2NCH3), 4.47 (s, 1H,
CCH2NCH3), 5.33 (s, 1H, ArCH2OCO), 5.35 (s, 1H, ArCH2OCO),
6.92 (t, J = 8.3 Hz, 1H, FCCH), 6.97−7.06 (m, 2H, CH2CCH), 7.16−
7.25 (m, 1H, FCCH); 19F NMR (376 MHz, chloroform-d) δ −146.37
(ddd, J = 63.0, 31.2, 18.8 Hz), −114.67; 13C NMR (101 MHz,
chloroform-d) δ 12.6, 12.7, 33.7, 35.4, 52.04, 52.2, 58.5, 58.6, 115.4,
115.5, 115.6, 115.7, 123.5, 128.6, 128.7, 129.4, 129.5, 130.9, 131.1,
132.5, 132.6, 134.5, 134.6, 136.3, 153.6, 155.2, 155.3, 155.7, 155.8;





Fluorobenzyl)(methyl)carbamate (13). Method A. To a solution of
compound 5 (50 mg, 83.2 μmol) in dry THF (10 mL) was added a
solution of pyridine in THF (0.50 M, 0.17 mL, 54 μmol, 0.24 equiv)
under a nitrogen atmosphere. After the mixture was stirred for 15 min
at room temperature, a solution of 4-ﬂuoro-N-methylbenzylamine in
THF (0.50 M, 0.16 mL, 74.9 μmol, 0.90 equiv) was added. The
reaction was then stirred for an additional 3 h. After that time, DCM
(20 mL) and brine (20 mL) were added and the formed phases were
separated. After the organic layer was washed with 1 M HCl (3 × 20
mL), 0.1 M NaOH (4 × 20 mL), and brine (2 × 20 mL), it was dried
with MgSO4 and the solvent was evaporated. The crude mixture was
then puriﬁed by ﬂash chromatography using pentane/diethyl ether
(3:1; v/v) as the eluent. The product was obtained as a dark violet
precipitate (16 mg, 32%).
Method B. To a solution of compound 11 (10 mg, 23 μmol) in dry
THF (0.5 mL) was added a solution of NBS (12 mg, 70 μmol, 3
equiv) in dry THF (0.5 mL) under a nitrogen atmosphere. The
reaction was then stirred at room temperature for 0.5 h. After this
time, the crude mixture was puriﬁed by ﬂash chromatography using
DCM as the eluent. The product was obtained as a purple precipitate
(11 mg, 81%).
Compound data: Rf = 0.7 (DCM); mp = 168−170 °C; 1H NMR
(400 MHz, chloroform-d) δ 2.30 (s, 3H, ArCH3), 2.42 (s, 3H,
ArCH3), 2.59 (s, 6H, 2 × ArCH3), 2.78 (s, 1.5H, NCH3), 3.00 (s,
1.5H, NCH3), 4.33 (s, 1H, CCH2NCH3), 4.47 (s, 1H, CCH2NCH3),
5.33 (s, 1H, ArCH2OCO), 5.35 (s, 1H, ArCH2OCO), 6.92 (t, J = 8.2
Hz, 1H, FCCH), 6.96−7.08 (m, 2H, CH2CCH), 7.18−7.24 (m, 1H,
FCCH); 19F NMR (376 MHz, chloroform-d) δ −146.05 (ddd, J =
63.4, 31.2, 20.9 Hz), −114.67, −114.57; 13C NMR (101 MHz,
chloroform-d) δ 13.9, 14.7, 33.7, 35.4, 52.1, 52.2, 58.6, 58.7, 112.8,
112.9, 115.4, 115.5, 115.6, 115.7, 128.6, 128.7, 129.4, 129.5, 131.6,
131.8, 132.6, 132.6, 134.1, 134.2, 138. 9, 154.9, 155.2, 155.7, 160.9,
161.1, 163.4, 163.5; HRMS (ESI+) calcd for [M + NH4]
+
(C23H27BBr2F3N4O2) 619.0520, found 619.0518.
(2,8-Diiodo-5,5-diﬂuoro-1,3,7,9-tetramethyl-5H-4λ4,5λ4-
dipyrrolo[1,2-c:2′,1′-f ][1,3,2]diazaborinin-10-yl)methyl (4-
Fluorobenzyl)(methyl)carbamate (14). Method A. To a solution of
compound 6 (50 mg, 72.0 μmol) in dry THF (10 mL) was added a
solution of pyridine in THF (0.50 M, 0.14 mL, 64.8 μmol, 0.24 equiv)
under a nitrogen atmosphere. After the mixture was stirred for 15 min
at room temperature, a solution of 4-ﬂuoro-N-methylbenzylamine in
THF (0.50 M, 0.13 mL, 72.0 μmol, 0.90 equiv) was added. The
reaction was then stirred for an additional 3 h. After that time, DCM
(20 mL) and brine (20 mL) were added and the formed phases were
separated. After the organic layer was washed with 1 M HCl (3 × 20
mL), 0.1 M NaOH (4 × 20 mL), and brine (2 × 20 mL), it was dried
with MgSO4 and the solvent was evaporated. The crude mixture was
then puriﬁed by ﬂash chromatography using pentane/diethyl ether
(3:1; v/v) as the eluent. The product was obtained as a dark violet
precipitate (16 mg, 34%).
Method B. To a suspension of compound 11 (10 mg, 23 μmol) and
ZnO (6.6 mg, 81 μmol, 3.6 equiv) in dry THF (0.5 mL) was added a
solution of ICl (11 mg, 68 μmol, 3.0 equiv) in dry THF (0.5 mL) at 0
°C in a nitrogen atmosphere. The reaction was allowed to stir for 10
min, after which the solvent was evaporated and the crude mixture
ﬁltrated through silica using DCM. The product was obtained as a
dark violet precipitate (12 mg, 73%).
Compound data: Rf = 0.7 (DCM); mp = 193−194 °C; 1H NMR
(400 MHz, chloroform-d) δ 2.33 (s, 3H, ArCH3), 2.45 (s, 3H,
ArCH3), 2.63 (s, 6H, 2 × ArCH3), 2.79 (s, 1.5H, 0.5 × NCH3), 3.00
(s, 1.5H, 0.5 × NCH3), 4.33 (s, 1H, CCH2NCH3), 4.47 (s, 1H,
CCH2NCH3), 5.34 (s, 1H, ArCH2OCO), 5.36 (s, 1H, ArCH2OCO),
6.93 (t, J = 8.3 Hz, 1H, FCCH), 6.98−7.10 (m, 2H, CH2CCH), 7.21
(t, J = 5.3 Hz, 1H, FCCH); 19F NMR (376 MHz, chloroform-d) δ
−145.69 (ddd, J = 63.0, 30.7, 22.6 Hz), −114.67, −114.42; 13C NMR
(101 MHz, chloroform-d) δ 16.3, 18.0, 33.7, 35.4, 52.1, 52.2, 58.9,
59.0, 87.1, 115.4, 115.5, 115.7, 115.7, 128.7, 128.8, 129.4, 129.5, 132.5,
132.6, 132.7, 133.2, 133.3, 143.6, 155.2, 155.8, 157.8; HRMS (ESI+)
calcd for [M + NH4]
+ (C23H27BF3I2N4O2) 713.0269, found 713.0266.
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Feringa, B. L. Bioconjugate Chem. 2015, 26, 2592−2597.
(6) (a) Hansen, M. J.; Velema, W. A.; Lerch, M. M.; Szymański, W.;
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D.; Slanina, T.; Klań, P. Chem. Commun. 2016, 52, 12901−12904.
(d) Klań, P.; Šolomek, T.; Bochet, C. G.; Blanc, A.; Givens, R.; Rubina,
M.; Popik, V.; Kostikov, A.; Wirz, J. Chem. Rev. 2013, 113, 119−191.
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J. Am. Chem. Soc. 2017, 139, 15168−15175.
(38) Umeda, N.; Takahashi, H.; Kamiya, M.; Ueno, T.; Komatsu, T.;
Terai, T.; Hanaoka, K.; Nagano, T.; Urano, Y. ACS Chem. Biol. 2014,
9, 2242−2246.
(39) Krumova, K.; Cosa, G. J. Am. Chem. Soc. 2010, 132, 17560−
17569.
(40) Beh, M. H. R.; Douglas, K. I. B.; House, K. T. E.; Murphy, A. C.;
Sinclair, J. S. T.; Thompson, A. Org. Biomol. Chem. 2016, 14, 11473−
11479.
(41) Zhu, H.; Fan, J.; Li, M.; Cao, J.; Wang, J.; Peng, X. Chem. - Eur.
J. 2014, 20, 4691−4696.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.7b02729
J. Org. Chem. 2018, 83, 1819−1827
1827
